ONCOSEC MED INC's ticker is ONCSXXXX and the CUSIP is 68234L207. A total of 22 filers reported holding ONCOSEC MED INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $519,000 | -12.9% | 931,923 | -0.0% | 0.00% | – |
| Q4 2018 | $596,000 | -78.3% | 932,323 | -52.4% | 0.00% | – |
| Q3 2018 | $2,741,000 | +1.8% | 1,958,227 | +0.3% | 0.00% | – |
| Q2 2018 | $2,693,000 | -25.3% | 1,951,560 | +1.8% | 0.00% | – |
| Q1 2018 | $3,605,000 | +181.6% | 1,917,644 | +143.5% | 0.00% | – |
| Q4 2017 | $1,280,000 | +191.6% | 787,649 | +71.8% | 0.00% | – |
| Q3 2017 | $439,000 | -18.7% | 458,511 | +1.1% | 0.00% | – |
| Q2 2017 | $540,000 | -25.2% | 453,611 | -19.6% | 0.00% | – |
| Q1 2017 | $722,000 | +39.9% | 564,106 | +34.4% | 0.00% | – |
| Q4 2016 | $516,000 | -31.8% | 419,781 | -5.1% | 0.00% | – |
| Q3 2016 | $757,000 | +7.4% | 442,404 | +2.9% | 0.00% | – |
| Q2 2016 | $705,000 | -33.7% | 430,031 | +3.1% | 0.00% | – |
| Q1 2016 | $1,063,000 | +10.7% | 417,006 | +2.9% | 0.00% | – |
| Q4 2015 | $960,000 | -50.5% | 405,062 | +7.5% | 0.00% | – |
| Q3 2015 | $1,941,000 | – | 376,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 2,064,297 | $3,881,000 | 0.64% |
| Avoro Capital Advisors LLC | 4,007,696 | $7,534,000 | 0.36% |
| Crestline Management, LP | 201,860 | $379,000 | 0.05% |
| Point72 Asset Management, L.P. | 3,215,000 | $6,044,000 | 0.02% |
| Sofinnova Investments, Inc. | 66,965 | $126,000 | 0.02% |
| FNY Managed Accounts LLC | 10,000 | $18,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 269,432 | $507,000,000 | 0.01% |
| DRW Securities, LLC | 70,000 | $132,000 | 0.01% |
| Perceptive Advisors | 50,000 | $94,000 | 0.00% |
| Cable Hill Partners, LLC | 4,000 | $8,000 | 0.00% |